Contradicting results for chemoimmunotherapy in metastatic TNBC ConferenceESMO 2020 TypePeer-reviewed article 25 November 2020 16:01
No higher pathologic complete response with atezolizumab added to chemotherapy TrialIMpassion130 ConferenceSABCS 2019 TypePeer-reviewed article 13 February 2020 23:54
ImPassion130 brings breast cancer into the immunotherapy era TrialPhase 3, ImPassion130 ConferenceASCO 2019 TypePeer-reviewed article 15 July 2019 11:27